TELA Bio Awarded Biosynthetic Mesh Products Agreement with a National Group Purchasing Organization

14.02.2023 - MALVERN, Pa., Feb. 14, 2023 (GLOBE NEWSWIRE) - TELA Bio, Inc. (NASDAQ: TELA), a commercial-stage medical technology company focused on providing innovative technologies that optimize clinical outcomes by prioritizing the preservation and ...

Related Keywords

Antony Koblish ,Greg Chodaczek ,Alyson Kuritz ,Exchange Commission ,Bio Inc ,Nasdaq ,Ovitex Reinforced Tissue Matrix ,Tex Reinforced Tissue Matrix ,Private Securities Litigation Reform Act ,Annual Report ,Quarterly Reports ,